Rather they ran a trial using Bavi in patients co-infected with HCV and HIV. They expect to report this mid-year.
I was aware of the trial - 24 patients on an 8 week trial taking 3-1/2 years to complete. Hence my language in the previous post: "no significant trials since then"
I think it is pretty clear that they are not excited about this drug in any HCV indication.
Market Data 
Markets 
AI
